BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3502343)

  • 1. Newly synthesized compound, PABA-ursodeoxycholic acid, for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Matsuno K; Tamura H; Furuyashiki S; Harada M
    Hiroshima J Med Sci; 1987 Dec; 36(4):377-81. PubMed ID: 3502343
    [No Abstract]   [Full Text] [Related]  

  • 2. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M; Tashiro H; Akazawa F
    J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M
    J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.
    Takahashi M; Maeda Y; Tashiro H; Akazawa F; Okajima M; Yoshioka S; Matsugu Y; Toyota K; Masaoka Y
    Scand J Gastroenterol; 1991 Jun; 26(6):577-88. PubMed ID: 1862298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new simple test for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
    World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ursodeoxycholic acid 7-oleyl ester to enzymatic hydrolysis.
    Marzo A; Treffner E; Sansó G; Rapelli S
    Boll Chim Farm; 1985 Mar; 124(3):150-2. PubMed ID: 4027025
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
    Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
    Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Direct conversion of ursodeoxycholic acid to chenodeoxycholic acid by human intestinal microorganisms under the anaerobic condition (author's transl)].
    Higashi S; Setoguchi T; Katsuki T
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jan; 77(1):113. PubMed ID: 7359762
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, intestinal absorption and metabolism of sarcosine conjugated ursodeoxycholic acid.
    Kimura M; Hatono S; Une M; Fukuoka C; Kuramoto T; Hoshita T
    Steroids; 1984 Jun; 43(6):677-87. PubMed ID: 6533845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of p-aminobenzoic acid and its metabolites in urine and plasma by ion pair HPLC in the NBT-PABA pancreatic function test.
    Hung CT; Perrier DG; Schicker AM; Zoest AR
    Biomed Chromatogr; 1987 Feb; 2(1):13-6. PubMed ID: 3509869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro transformation of cheno- and ursodeoxycholic acids and their 7-oleyl esters by human intestinal microflora.
    Ferrari A; Pacini N; Sirtori CR; Kritchevsky D
    Proc Soc Exp Biol Med; 1988 May; 188(1):108-11. PubMed ID: 3368473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 60-minute blood p-aminobenzoic acid concentration in pancreatic function testing of dogs.
    Strombeck DR; Harrold D
    J Am Vet Med Assoc; 1982 Feb; 180(4):419-21. PubMed ID: 6977519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and hepatic metabolism of ursulcholic acid (a soluble form of ursodeoxycholic acid in the rat].
    Franzone JS; Santiano M; Reboani C; Grigolo B; Simoni P
    Boll Chim Farm; 1987 Jul; 126(7):289-93. PubMed ID: 3452329
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of pancreatic exocrine function with the synthetic peptide BT-PABA in diabetes mellitus.
    Yokoyama J; Ohno M; Tajima N; Kageyama S; Ikeda Y; Tanese T; Abe M
    Mt Sinai J Med; 1982; 49(1):18-22. PubMed ID: 6979679
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurements of the photodegradation of PABA and some PABA derivatives.
    Flindt-Hansen H; Nielsen CJ; Thune P
    Photodermatol; 1988 Dec; 5(6):257-60. PubMed ID: 3266895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
    Konishi T
    Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of bile acids. XIV. Sarcosine conjugated bile acids].
    Hatono S; Hironaka Y; Kuramoto T; Hoshita T
    Yakugaku Zasshi; 1984 May; 104(5):466-71. PubMed ID: 6491885
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal absorption of ursodeoxycholic, glycoursodeoxycholic and tauroursodeoxycholic acids in rats.
    Ota M; Minami Y; Hoshita T
    J Pharmacobiodyn; 1985 Feb; 8(2):114-8. PubMed ID: 4009402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between nitro group reduction and the intestinal microflora.
    Wheeler LA; Soderberg FB; Goldman P
    J Pharmacol Exp Ther; 1975 Jul; 194(1):135-44. PubMed ID: 1097637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal absorption and metabolism of homoursodeoxycholic acid in rats.
    Kuramoto T; Moriwaki S; Kawamoto K; Hoshita T
    J Pharmacobiodyn; 1987 Jul; 10(7):309-16. PubMed ID: 3694424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.